Drug Pipeline

Evorpacept Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
5
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-06 NCT07007559
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in…		 Trial sites expanded: 32 -> 44 locations
Active Studies by Phase
Phase 2
3
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07007559 ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in… Breast Cancer, Metastatic Recruiting
NCT05467670 Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and… Ovarian Cancer Active, Not Recruiting
NCT05787639 Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human… Oropharynx Cancer Active, Not Recruiting
Phase 1/2
NCT04643002 Isatuximab in Combination With Novel Agents in RRMM - Master Protocol Plasma Cell Myeloma Refractory Recruiting
NCT05025800 ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell… Aggressive B-Cell Non-Hodgkin Lymphoma Active, Not Recruiting
Sponsors Running Evorpacept Trials
Sanofi (1) M.D. Anderson Cancer Center (1) Alexander B Olawaiye, MD (1) University of California, San Diego (1) ALX Oncology Inc. (1)
Disease Areas
Multiple Myeloma (1) Non-Hodgkin Lymphoma (1) DLBCL (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1) Ovarian Cancer (1) Breast Cancer (1)
Get alerts when Evorpacept trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free